Abstract
The normal human stomach is devoid of any organized lymphatic tissue. Acquisition of mucosa-associated lymphatoid tissue (MALT) in the stomach is considered to be a direct consequence of chronic infection with Helicobacter pylori. Thus, MALT appears to be part of the host defense against the pathogen H. pylori. Consequently, lymphomas arising from gastric MALT may be seen as an end point of a clonal evolution starting from the infection. Cumulative data from several studies show that eradication of H. pylori induces complete histologic remissions in about 70%–80% of the patients. Here we present data of an extended analysis of an ongoing multicenter trial. Eightyfour patients with low-grade gastric MALT lymphoma in stage EI were treated using a dual regimen to eradicate H. pylori. Complete remission was observed in 68 (81%) patients; a partial remission was found in seven (8%) patients. In contrast, nine (11%) patients revealed “no change” and were referred for alternative treatment strategies. The majority of these cases were found to harbor high-grade lymphomas in deeper mucosal areas. Polymerase chain reaction (PCR) performed on the VDJ rearrangements of the immunoglobulin heavy chain yielded monoclonal bands in 50 of 65 analyzed patients (77%) at diagnosis. Interestingly, in patients analyzed during follow up after achieving complete histologic remission, ongoing PCR monoclonality was found in 19 of 39 eligible patients (49%). Several patients who developed local relapse of the lymphoma were found in the group with ongoing PCR monoclonality. Together with data from the literature, these results suggest that the majority of low-grade gastric MALT lymphomas in stage EI respond to eradication of H. pylori. Longer follow-up investigations are necessary to determine whether remissions really indicate a cure from the disease and to elucidate whether PCR monoclonality after complete histological remission is predictive of increased relapse rate.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Stolte M (1996) Pathologie der Helicobacter pylori-Krankheiten. In: Malfertheiner P (ed) Helicobacter pylori — von der Grundlage zur Therapie. Thieme, Stuttgart, pp 37–61
Stolte M, Eidt S (1989) Lymphoid follicles in antral mucosa: immune response to Campylobacter pylori. J Clin Pathol 42:1269–1271
Eidt S, Stolte M (1993) Prevalence of lymphoid follicles and aggregates in Helicobacter pylori gastritis in antral and body mucosa. J Clin Pathol 46:832–835
Isaacson PG, Wright DH (1983) Malignant lymphoma of mucosa-associated tissue. A distinctive type of B-cell lymphoma. Cancer 52:1410–1416
Warren JR (1983) Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1:1273
Wotherspoon AC, Ortiz Hidalgo C, Falzon MR, Isaacson PG (1991) Helicobacter pyloriassociated gastritis and primary B-cell gastric lymphoma (see comments). Lancet 338:1175–1176
Stolte M, Eidt S (1993) Healing gastric MALT lymphomas by eradicating H pylori? (Comment) Lancet 342:568
Rudolph B, Bayerdorffer E, Ritter M, Muller S, Thiede C, Neubauer B, Lehn N, Seifert E, Otto P, Hatz R, Stolte M, Neubauer A (1997) Is the polymerase chain reaction or cure of Helicobacter pylori infection of help in the differential diagnosis of early gastric mucosa-associated lymphatic tissue lymphoma? J Clin Oncol 15:1104–1109
Savio A, Franzin G, Wotherspoon AC, Zamboni G, Negrini R, Buffoli F, Diss TC, Pan L, Isaacson PG (1996) Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: histology, polymerase chain reaction, or both? Blood 87:1255–1260
Zueca E, Bertoni F, Roggero E, Bosshard G, Cazzaniga G, Pedrinis E, Biondi A, Cavalli F (1998) Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. N Engl J Med 338:804–810
Isaacson PG, Spencer J (1987) Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology 11:445–462
Nakamura S, Akazawa K, Kinukawa N, Yao T, Tsuneyoshi M (1996) Inverse correlation between the expression of bcl-2 and p53 proteins in primary gastric lymphoma (see comments). Hum Pathol 27:225–233
Thiede C, Morgner A, Alpen B, Wundisch T, Herrmann J, Ritter M, Ehninger G, Stolte M, Bayerdorffer E, Neubauer A (1997) What role does Helicobacter pylori eradication play in gastric MALT and gastric MALT lymphoma?. Gastroenterology 113:S61–S64
Greiner A, Knorr C, Qin Y, Sebald W, Schimpl A, Banchereau J, Muller Hermelink HK (1997) Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation. Am J Pathol 150:1583–1593
Wotherspoon AC, Pan L, Diss TC, Isaacson PG (1990) A genotypic study of low-grade B-cell lymphomas, including lymphomas of mucosa associated lymphoid tissue (MALT). J Pathol 162:135–140
Ott G, Katzenberger T, Greiner A, Kalla J, Rosenwald A, Heinrich U, Ott MM, Muller Hermelink HK (1997) The t(ll;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin’s lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res 57:3944–3948
Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG (1993) Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori (see comments). Lancet 342:575–577
Stolte M (1992) Helicobacter pylori gastritis and gastric MALT-lymphoma (letter; comment). Lancet 339:745–746
Bayerdorffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, Stolte M (1995) Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group (see comments). Lancet 345:1591–1594
Roggero E, Zucca E, Cavalli F (1997) Gastric mucosa-associated lymphoid tissue lymphomas: more than a fascinating model (editorial; comment). J Natl Cancer Inst 89: 1328–1330
Sackmann M, Morgner A, Rudolph B, Neubauer A, Thiede C, Schulz H, Kraemer W, Boersch G, Rohde P, Seifert E, Stolte M, Bayerdoerffer E (1997) Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group. Gastroenterology 113:1087–1090
Boot H, de Jong D, van Heerde P, Taal B (1995) Role of Helicobacter pylori eradication in high-grade MALT lymphoma (letter; comment). Lancet 346:448–449
Neubauer A, Thiede C, Morgner A, Alpen B, Ritter M, Neubauer B, Wundisch T, Ehninger G, Stolte M, Bayerdorffer E (1997) Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma (see comments). J Natl Cancer Inst 89:1350–1355
Enno A, O’Rourke JL, Howlett CR, Jack A, Dixon MF, Lee A (1995) MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis. A mouse model of Helicobacter pylori-induced gastric lymphoma. Am J Pathol 147: 217–222
Roggero E, Zucca E, Pinotti G, Pascarella A, Capella C, Savio A, Pedrinis E, Paterlini A, Venco A, Cavalli F (1995) Eradication of Helicobacter pylori infection in primary lowgrade gastric lymphoma of mucosa-associated lymphoid tissue (see comments). Ann Intern Med 122:767–769
Fischbach W, Kolve ME, Engemann R, Greiner A, Stolte M (1996) Unexpected success of Helicobacter pylori eradication in low-grade lymphoma. Gastroenterology 110:A512 (abstract)
Montalban C, Manzanal A, Boixeda D, Redondo C, Alvarez I, Calleja JL, Bellas C (1997) Helicobacter pylori eradication for the treatment of low-grade gastric MALT lymphoma: follow-up together with sequential molecular studies. Ann Oncol 8[Suppl 2]:37–39
Pinotti G, Zucca E, Roggero E, Pascarella A, Bertoni F, Savio A, Savio E, Capella C, Pedrinis E, Saletti P, Morandi E, Santandrea G, Cavalli F (1997) Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk Lymphoma 26:527–537
Nobre-Leitao C, Lage P, Cravo M, Cabecadas J, Chaves P, Alberto-Santos A, Correia J, Soares J, Costa-Mira F (1998) Treatment of gastric MALT lymphoma by Helicobacter pylori eradication: a study controlled by endoscopic ultrasonography. Am J Gastroenterol 93:732–736
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Thiede, C. et al. (2000). Eradication of Helicobacter pylori and Stability of Remissions in Low-Grade Gastric B-Cell Lymphomas of the Mucosa-Associated Lymphoid Tissue: Results of an Ongoing Multicenter Trial. In: Fischbach, W. (eds) Gastrointestinal Lymphoma. Recent Results in Cancer Research, vol 156. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57054-4_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-57054-4_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62984-6
Online ISBN: 978-3-642-57054-4
eBook Packages: Springer Book Archive